NRIX•benzinga•
Nurix Therapeutics Prersents Data From Ongoing Phase 1a/b Clinical Trial Of Bexobrutideg In Patients With r/r CLL And Waldenström Macroglobulinemia At EHA Congress 2025 And 18-ICML
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 14, 2025 by benzinga